Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NeoGenomics Inc. Common Stock (NEO) vs Primo Brands Corporation Class A Common Stock (PRMB) Price & Performance

NeoGenomics Inc. Common StockTrade
Primo Brands Corporation Class A Common StockTrade

Price performance (Past 24H)

Key statistics

NeoGenomics Inc. Common Stock vs Primo Brands Corporation Class A Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B), while Primo Brands Corporation Class A Common Stock trades at $18.76 (market cap $6.84B). The key difference: Primo Brands Corporation Class A Common Stock is far larger — about 3.2× NeoGenomics Inc. Common Stock's market cap, and Primo Brands Corporation Class A Common Stock pays a 2.54% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Primo Brands Corporation Class A Common Stock for 0 Days on average.

NEOPRMB
Market Cap
$2.14B$6.84B
Volume
2,228,4002,864,594
Sector
HealthConsumer Staples
52-Week High
$19.91$25.39
52-Week Low
$7.19$14.46
Typical Hold Time
0 Days0 Days
Enterprise Value
$2.44B$12.17B
Dividend Yield
—2.54%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Primo Brands Corporation Class A Common Stock

PRMB trades at $18.9, down 1.46% on the day, with a neutral technical signal and key support/resistance clustered around $19. The company reported Q2 2026 EPS of $0.37, beating expectations, and shows improving revenue and net income trends for 2026. Recent news highlights expansion with a new factory opening and strong premium water sales growth, supporting a positive analyst consensus.

The outlook is positive, driven by sales momentum and capacity expansion, but risks include thin net margins and high P/E ratio. With 80% of analysts rating it Buy and a consensus price target of $28.50, the stock offers significant upside potential if execution continues, though margin pressure remains a key watchpoint.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEO
100% Buy0% Sell
Avg holding period · 0 Days
PRMB
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →

About Primo Brands Corporation Class A Common Stock

Primo Brands Corporation is a branded beverage company that produces and distributes packaged and purified water, water dispensers, and filtration equipment across North America, under brands including Poland Spring, Pure Life, Arrowhead, and Primo Water.

Read more on PRMB →